Literature DB >> 25117799

Recent developments in the search for a cure for HIV-1 infection: targeting the latent reservoir for HIV-1.

Janet D Siliciano1, Robert F Siliciano2.   

Abstract

HIV-1 infection can now be readily controlled with combination antiretroviral therapy. However, the virus persists indefinitely in a stable latent reservoir in resting CD4(+) T cells. This reservoir generally prevents cure of the infection with combination antiretroviral therapy alone. However, several recent cases of potential HIV-1 cure have generated renewed optimism. Here we review these cases and consider new developments in our understanding of the latent reservoir. In addition, we consider clinical aspects of curative strategies to provide a more realistic picture of what a generally applicable cure for HIV-1 infection is likely to entail.
Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  HIV; antiretroviral therapy; cure; eradication; latency; reservoir; stem cell transplantation

Mesh:

Substances:

Year:  2014        PMID: 25117799     DOI: 10.1016/j.jaci.2014.05.026

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  40 in total

1.  Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity.

Authors:  Li Liu; Bhavik Patel; Mustafa H Ghanem; Virgilio Bundoc; Zhili Zheng; Richard A Morgan; Steven A Rosenberg; Barna Dey; Edward A Berger
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

2.  AIDS virus seeks refuge in B cell follicles.

Authors:  Hendrik Streeck
Journal:  Nat Med       Date:  2015-02       Impact factor: 53.440

Review 3.  HIV therapeutic vaccines: moving towards a functional cure.

Authors:  Geetha H Mylvaganam; Guido Silvestri; Rama Rao Amara
Journal:  Curr Opin Immunol       Date:  2015-05-18       Impact factor: 7.486

Review 4.  Roles of microRNAs and long-noncoding RNAs in human immunodeficiency virus replication.

Authors:  Andrew P Rice
Journal:  Wiley Interdiscip Rev RNA       Date:  2015-09-22       Impact factor: 9.957

Review 5.  Cyclin-dependent kinases as therapeutic targets for HIV-1 infection.

Authors:  Andrew P Rice
Journal:  Expert Opin Ther Targets       Date:  2016-11-10       Impact factor: 6.902

6.  HIV Excision Utilizing CRISPR/Cas9 Technology: Attacking the Proviral Quasispecies in Reservoirs to Achieve a Cure.

Authors:  Will Dampier; Michael R Nonnemacher; Neil T Sullivan; Jeffrey M Jacobson; Brian Wigdahl
Journal:  MOJ Immunol       Date:  2014-10-17

7.  Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo.

Authors:  Francesco R Simonetti; Michele D Sobolewski; Elizabeth Fyne; Wei Shao; Jonathan Spindler; Junko Hattori; Elizabeth M Anderson; Sarah A Watters; Shawn Hill; Xiaolin Wu; David Wells; Li Su; Brian T Luke; Elias K Halvas; Guillaume Besson; Kerri J Penrose; Zhiming Yang; Richard W Kwan; Carter Van Waes; Thomas Uldrick; Deborah E Citrin; Joseph Kovacs; Michael A Polis; Catherine A Rehm; Robert Gorelick; Michael Piatak; Brandon F Keele; Mary F Kearney; John M Coffin; Stephen H Hughes; John W Mellors; Frank Maldarelli
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

Review 8.  Leveraging Cancer Therapeutics for the HIV Cure Agenda: Current Status and Future Directions.

Authors:  Mark N Polizzotto; Grace Chen; Randall L Tressler; Catherine Godfrey
Journal:  Drugs       Date:  2015-09       Impact factor: 9.546

Review 9.  Challenges and strategies for the eradication of the HIV reservoir.

Authors:  Jason T Kimata; Andrew P Rice; Jin Wang
Journal:  Curr Opin Immunol       Date:  2016-06-09       Impact factor: 7.486

10.  Human T-Cell Development and Thymic Egress: An Infectious Disease Perspective.

Authors:  Rachel S Resop; Christel H Uittenbogaart
Journal:  For Immunopathol Dis Therap       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.